Emerald Mutual Fund Advisers Trust Has $8.80 Million Position in Orthofix Medical Inc. (NASDAQ:OFIX)

Emerald Mutual Fund Advisers Trust boosted its holdings in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 35.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 503,802 shares of the medical device company's stock after purchasing an additional 131,653 shares during the period. Emerald Mutual Fund Advisers Trust owned 1.32% of Orthofix Medical worth $8,796,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. raised its holdings in shares of Orthofix Medical by 244.1% in the fourth quarter. JPMorgan Chase & Co. now owns 290,351 shares of the medical device company's stock valued at $5,070,000 after buying an additional 205,972 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Orthofix Medical by 31.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 659,475 shares of the medical device company's stock worth $11,515,000 after purchasing an additional 159,177 shares in the last quarter. Emerald Advisers LLC grew its stake in shares of Orthofix Medical by 12.2% during the fourth quarter. Emerald Advisers LLC now owns 822,377 shares of the medical device company's stock valued at $14,359,000 after purchasing an additional 89,717 shares during the last quarter. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Orthofix Medical in the fourth quarter valued at approximately $1,286,000. Finally, Teacher Retirement System of Texas raised its position in Orthofix Medical by 90.0% in the 4th quarter. Teacher Retirement System of Texas now owns 135,009 shares of the medical device company's stock worth $2,357,000 after purchasing an additional 63,939 shares during the last quarter. 89.76% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

OFIX has been the subject of a number of recent research reports. Canaccord Genuity Group restated a "buy" rating and set a $24.00 target price on shares of Orthofix Medical in a research report on Wednesday, February 26th. Roth Mkm restated a "buy" rating and set a $22.00 target price on shares of Orthofix Medical in a research report on Wednesday, February 26th. Finally, StockNews.com raised shares of Orthofix Medical from a "hold" rating to a "buy" rating in a research note on Tuesday, February 25th. Five research analysts have rated the stock with a buy rating, According to MarketBeat.com, Orthofix Medical currently has a consensus rating of "Buy" and an average price target of $23.33.

Insider Activity at Orthofix Medical

In other news, insider Lucas Vitale sold 4,287 shares of Orthofix Medical stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $16.60, for a total transaction of $71,164.20. Following the transaction, the insider now owns 135,317 shares in the company, valued at $2,246,262.20. The trade was a 3.07 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Jorge Andres Cedron sold 3,816 shares of the stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $13.31, for a total value of $50,790.96. Following the sale, the insider now directly owns 42,500 shares of the company's stock, valued at approximately $565,675. The trade was a 8.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 9,242 shares of company stock worth $141,710 in the last ninety days. Company insiders own 2.60% of the company's stock.

Orthofix Medical Trading Up 1.8 %

NASDAQ:OFIX traded up $0.24 during mid-day trading on Friday, hitting $13.79. The company had a trading volume of 160,277 shares, compared to its average volume of 256,748. The firm has a market cap of $538.11 million, a P/E ratio of -4.41 and a beta of 0.99. Orthofix Medical Inc. has a fifty-two week low of $12.08 and a fifty-two week high of $20.73. The business's fifty day moving average is $15.41 and its two-hundred day moving average is $17.04. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.11 and a current ratio of 2.39.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.